Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/31/16  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Donald R. Marvin

Wrong Donald R. Marvin?

President and Chief Executive Off...

Phone: (303) ***-****  
Local Address:  Montréal , Quebec , Canada
Inocucor Technologies Inc
7220 Frederick-Banting Suite 100
Montr al , Quebec h4s 2a1
Canada

Company Description: At Inocucor Technologies, Inc. we are dedicated to developing, manufacturing and marketing breakthrough products for the phyto-microbiome. We are currently seeking...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • M.B.A. , organizational behavior and finance
    Iona College
  • B.S. , microbiology
    The Ohio State University
  • M.B.A. , microbiology
    The Ohio State University
  • B.S. , microbiology
    Ohio State University
166 Total References
Web References
Our Team | Inocucor Technologies
inocucor.com, 2 Feb 2015 [cached]
Donald R. Marvin, M.B.A.President and Chief Executive Officer & Director
Mr. Marvin has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 30 years.
Prior to joining Inocucor™ Technologies, he was the president and CEO of Cairn Associates Inc., a biotechnology, life science and consumer products strategy development and financial advisory firm.
Most recently, Mr. Marvin was the president and CEO of IdentiGEN, Inc., a leading provider of DNA-based solutions to the agriculture and food industries. He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.
Previously, Mr. Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry.
His expertise includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Mr. Marvin is a serial entrepreneur with a track record of building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey's CFO of the year, he has raised over $300 million in both private and public financings and completed nearly a dozen M&A transactions for his former companies. Mr. Marvin has served on the boards of several public and privately held companies and currently serves on the board of MicroBiome Therapeutics, Inc.
He earned a B.S. in microbiology from Ohio State University and an M.B.A. in organizational behavior and finance from Iona College.
...
Mr. Marvin has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 30 years.
Prior to joining Inocucor™ Technologies, he was the president and CEO of Cairn Associates Inc., a biotechnology, life science and consumer products strategy development and financial advisory firm.
Most recently, Mr. Marvin was the president and CEO of IdentiGEN, Inc., a leading provider of DNA-based solutions to the agriculture and food industries. He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.
Previously, Mr. Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry.
His expertise includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Mr. Marvin is a serial entrepreneur with a track record of building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey's CFO of the year, he has raised over $300 million in both private and public financings and completed nearly a dozen M&A transactions for his former companies. Mr. Marvin has served on the boards of several public and privately held companies and currently serves on the board of MicroBiome Therapeutics, Inc.
He earned a B.S. in microbiology from Ohio State University and an M.B.A. in organizational behavior and finance from Iona College.
Board of Directors | Microbiome Therapeutics
www.mbiome.com, 22 July 2015 [cached]
Donald R. Marvin, M.B.A. - Director
Independent Director Donald Marvin has over 25 years of leadership experience in the development and commercialization of novel diagnostic and research products. He is President and CEO of Cairn Associates, a life sciences strategy consulting and investment firm. Previously, Mr. Marvin was President and CEO of IdentiGEN, a leading provider of DNA-based solutions in the agriculture and food industries. He was a co-founder, CFO and Senior Vice President of Corporate Development of Orchid BioSciences, a pioneer in human DNA identity testing. Prior to Orchid, Mr. Marvin was President and CEO of Diatron Corp., a developer of fluorescence-based clinical diagnostic systems. Earlier in his career, he held positions in strategic planning, business development, operations and marketing at PepsiCo, Abbott Laboratories, Bayer and Boehringer Ingelheim. Mr. Marvin also serves as a Director of Melior Discovery. He received a B.S. degree from Ohio State University and an M.B.A. from Iona College.
Donald R. ...
www.nbafinkansas.org, 16 Jan 2008 [cached]
Donald R. Marvin
President and CEOIdentiGEN North America, Inc.
Donald Marvin has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 25 years.Before joining IdentiGEN, he was the president and CEO of Cairn Associates, Inc., a life sciences strategy consulting and investment firm.He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.Previously, Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry.His prior experience includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Marvin, named New Jersey's CFO of the Year 2001, is an experienced fund-raiser, having completed private and public financings that have raised over $250 million for his companies.He currently serves on the Board of Directors of Tepnel Life Sciences PLC and Melior Discovery, Inc.He received his B.S. degree from Ohio State University and his M.B.A. from Iona College.
Marvin currently lives in the greater Princeton, N.J., area with his wife, Kristine, and is in the process of relocating to the High Plains region.He participates in several angel investment groups and is the co-founder and former co-host of VentureTalkTM Radio, a show designed to bring together entrepreneurs, sources of capital and service providers.
Orchid BioSciences, Inc. Reports Third Quarter 2002 Financial Results
biz.yahoo.com [cached]
Operational -- Appointed Andrew P. Savadelis as chief financial officer and senior vice president of finance, replacing Donald R. Marvin, who remains as general manager of Orchid Diagnostics. -- Undertook restructuring actions intended to reduce future operating expenses, including the elimination of positions in corporate infrastructure and laboratories in Princeton.This brings the total number of positions eliminated since late 2001 to approximately 150, a decrease of approximately 21% in total staff.
Cairn Associates, Inc.
www.cairnassociates.com, 17 Sept 2013 [cached]
Donald Marvin, president and CEO of Cairn Associates, said, “We are pleased to have worked with the Validus Ventures team during the sale process. Validus’s strong management team and leading market position highly complement Where Food Comes From’s third-party identification, verification and traceability solutions for the food industry.�
...
Founded in 1995, Cairn Associates emerged from the rich and extensive history of its founder, Donald Marvin, who has over 30 years of experience as a senior executive in start-up and expansion situations in small, high growth and Fortune 50 companies.
Other People with the name "Marvin":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304